T. Rowe Price Associates’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$453K Buy
114,524
+24,985
+28% +$126K ﹤0.01% 2508
2025
Q4
$607K Buy
89,539
+4,700
+6% +$32.9K ﹤0.01% 2306
2025
Q3
$594K Buy
84,839
+5,536
+7% +$38.5K ﹤0.01% 2298
2025
Q2
$486K Buy
79,303
+28,119
+55% +$187K ﹤0.01% 2315
2025
Q1
$389K Buy
51,184
+4,738
+10% +$39.6K ﹤0.01% 2355
2024
Q4
$447K Buy
46,446
+7,189
+18% +$56K ﹤0.01% 2332
2024
Q3
$233K Buy
39,257
+1,510
+4% +$10K ﹤0.01% 2593
2024
Q2
$262K Buy
37,747
+4,769
+14% +$33.5K ﹤0.01% 2486
2024
Q1
$254K Buy
32,978
+3,806
+13% +$30.6K ﹤0.01% 2510
2023
Q4
$256K Sell
29,172
-23,857
-45% -$175K ﹤0.01% 2442
2023
Q3
$387K Sell
53,029
-1,424
-3% -$10.6K ﹤0.01% 2232
2023
Q2
$360K Buy
54,453
+1,457
+3% +$7.43K ﹤0.01% 2282
2023
Q1
$181K Buy
52,996
+8,233
+18% +$31.9K ﹤0.01% 2555
2022
Q4
$124K Buy
44,763
+12,722
+40% +$38K ﹤0.01% 2672
2022
Q3
$92K Buy
32,041
+7,106
+28% +$25.3K ﹤0.01% 2745
2022
Q2
$87K Buy
24,935
+700
+3% +$2.74K ﹤0.01% 2782
2022
Q1
$114K Buy
24,235
+2,482
+11% +$12.1K ﹤0.01% 2827
2021
Q4
$131K Sell
21,753
-30,898
-59% -$215K ﹤0.01% 2832
2021
Q3
$319K Sell
52,651
-2,600
-5% -$29.3K ﹤0.01% 2556
2021
Q2
$691K Sell
55,251
-9,449
-15% -$102K ﹤0.01% 2225
2021
Q1
$666K Buy
64,700
+31,600
+95% +$305K ﹤0.01% 2233
2020
Q4
$301K Buy
+33,100
New +$238K ﹤0.01% 2420
2018
Q4
Sell
-22,759
Closed -$141K 2584
2018
Q3
$141K Buy
22,759
+719
+3% +$3.25K ﹤0.01% 2505
2018
Q2
$141K Buy
22,040
+313
+1% +$2.23K ﹤0.01% 2500
2018
Q1
$151K Buy
21,727
+11,202
+106% +$130K ﹤0.01% 2453
2017
Q4
$133K Buy
+10,525
New +$128K ﹤0.01% 2481

Other funds holding MDXG